Articles

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

Losordo DW, Schatz RA, White CJ, et al.

access_time15 February, 2011

Transcoronary transplantation of progenitor cells after myocardial infarction.

Assmus B, Honold J, Schachinger V, et al.

access_time15 February, 2011

Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction:

Kang HJ, Lee HY, Na SH, et al.

access_time15 February, 2011

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction:

Kang HJ, Kim HS, Zhang SY, et al.

access_time15 February, 2011

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Hare JM, Traverse JH, Henry TD, et al.

access_time15 February, 2011

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.

Chen SL, Fang WW, Ye F, et al.

access_time15 February, 2011

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.

van der Laan A, Hirsch A, Nijveldt R, et al.

access_time15 February, 2011

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Lunde K, Solheim S, Aakhus S, et al.

access_time15 February, 2011

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

Janssens S, Dubois C, Bogaert J, et al.

access_time15 February, 2011

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction:

Tendera M, Wojakowski W, Ruzyllo W, et al.

access_time15 February, 2011